DK139101B - Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. - Google Patents

Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser.

Info

Publication number
DK139101B
DK139101B DK358875AA DK358875A DK139101B DK 139101 B DK139101 B DK 139101B DK 358875A A DK358875A A DK 358875AA DK 358875 A DK358875 A DK 358875A DK 139101 B DK139101 B DK 139101B
Authority
DK
Denmark
Prior art keywords
14beta
5beta
17beta
3beta
pyridazinyl
Prior art date
Application number
DK358875AA
Other languages
Danish (da)
English (en)
Other versions
DK139101C (sl
DK358875A (sl
Inventor
Cesare Casagrande
Giorgio Ferrari
Original Assignee
Siphar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar Sa filed Critical Siphar Sa
Publication of DK358875A publication Critical patent/DK358875A/da
Publication of DK139101B publication Critical patent/DK139101B/da
Application granted granted Critical
Publication of DK139101C publication Critical patent/DK139101C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK358875AA 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. DK139101B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1085574A CH621803A5 (sl) 1974-08-08 1974-08-08

Publications (3)

Publication Number Publication Date
DK358875A DK358875A (sl) 1976-02-09
DK139101B true DK139101B (da) 1978-12-18
DK139101C DK139101C (sl) 1979-05-21

Family

ID=4367535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358875AA DK139101B (da) 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser.

Country Status (12)

Country Link
US (1) US4000125A (sl)
JP (1) JPS5141372A (sl)
AR (1) AR217617A1 (sl)
BE (1) BE832271A (sl)
CA (1) CA1049499A (sl)
CH (1) CH621803A5 (sl)
DE (1) DE2534981A1 (sl)
DK (1) DK139101B (sl)
ES (1) ES440110A1 (sl)
FR (1) FR2281124A1 (sl)
GB (1) GB1484655A (sl)
SE (1) SE418401B (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144136B (it) * 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
US5373095A (en) * 1985-10-18 1994-12-13 The Upjohn Company Steroid compounds
IT1262931B (it) * 1992-01-16 1996-07-22 Zambon Spa Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
DK2206719T3 (en) * 2005-03-02 2015-01-26 Univ Maryland A pharmaceutical composition comprising 3-BETA-HYDROXY-17- (1-H-benzimidazol-1-yl) androsta-5, 16-DIEN
WO2009114658A2 (en) * 2008-03-12 2009-09-17 University Of Maryland, Baltimore Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer
US20100048524A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
GB2470700B (en) 2008-03-25 2012-08-08 Univ Maryland C-17 heteroaryl steroidal CYP17 inhibitors
US8785423B2 (en) * 2008-04-14 2014-07-22 University Of Maryland, Baltimore Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases
JP2012516900A (ja) 2009-02-05 2012-07-26 トーカイ ファーマシューティカルズ，インク． ステロイド性ｃｙｐ１７阻害剤／抗アンドロゲン剤の新しいプロドラッグ
GB2479693B (en) 2009-02-05 2014-04-09 Tokai Pharmaceuticals Inc Steroidal CYP17 inhibitors and their use in the treatment of cancer and prostate hyperplasia
AU2010279398A1 (en) * 2009-08-07 2012-03-08 Tokai Pharmaceuticals, Inc. Treatment of prostate cancer
WO2014153215A1 (en) 2013-03-14 2014-09-25 University Of Maryland,Baltimore Office Of Technology Transfer Androgen receptor down-regulating agents and uses thereof
JP2016528252A (ja) 2013-08-12 2016-09-15 トーカイ ファーマシューティカルズ， インコーポレイテッド アンドロゲン標的治療を使用する新生物障害の処置のためのバイオマーカー
EP3313858B1 (en) * 2015-06-29 2019-09-25 Universiteit Gent Methods for the site-selective coupling of a first agent to a second agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838163A (en) * 1968-11-22 1974-09-24 Hoffmann La Roche Substituted isoxazole derivatives as steroid intermediates

Also Published As

Publication number Publication date
CA1049499A (en) 1979-02-27
DK139101C (sl) 1979-05-21
GB1484655A (en) 1977-09-01
AR217617A1 (es) 1980-04-15
FR2281124A1 (fr) 1976-03-05
ES440110A1 (es) 1977-02-16
SE7508908L (sv) 1976-02-09
DE2534981A1 (de) 1976-02-19
DK358875A (sl) 1976-02-09
BE832271A (fr) 1975-12-01
CH621803A5 (sl) 1981-02-27
FR2281124B1 (sl) 1980-05-16
SE418401B (sv) 1981-05-25
JPS5141372A (sl) 1976-04-07
US4000125A (en) 1976-12-28

Similar Documents

Publication Publication Date Title
DK138655B (da) Fremgangsmåde til fremstilling af N-phosphonomethyl-glycin.
DK136718B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner.
DK138800B (da) Analogifremgangsmåde til fremstilling af 4-aminoquinazolinderivater.
DK136719B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner.
DK136075B (da) Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater.
DK135376B (da) Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser.
DK139101B (da) Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser.
DK135711B (da) Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer.
DK137835B (da) Analogifremgangsmåde til fremstilling af thienothiazinderivater.
DK139846B (da) Analogifremgangsmåde til fremstilling af 3-alkoxypyrazin-2-carboxamider.
DK135796B (da) Fremgangsmåde til fremstilling af alkyl-tert-alkylethere.
DK138321B (da) Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater.
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
DK135723B (da) Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner.
DK135538B (da) Fremgangsmåde til fremstilling af 17alfa-ethynyl-(5alfa)-2-androsten-17-beta-ol.
DK139682B (da) Analogifremgangsmåde til fremstilling af eburnameninderivater.
DK137043B (da) Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser.
DK132328B (da) Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on.
DK136313B (da) Analogifremgangsmåde til fremstilling af N-substituerede m-trifluormethylbenzylaminer.
DK138227B (da) Analogifremgangsmåde til fremstilling af substituerede xanthon-2-carboxylsyreforbindelser.
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
DK137449B (da) Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid.
DK138694B (da) Fremgangsmåde til fremstilling af phenylphosphonothiodichlorid.
DK137646B (da) Fremgangsmåde til fremstilling af 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxid.
DK140670B (da) Analogifremgangsmåde til fremstilling af ergopeptinderivater.